Inappropriate prescribing and adverse drug events in older people
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Inappropriate prescribing (IP) in older patients is highly prevalent and is associated with an increased risk of adverse drug events (ADEs), morbidity, mortality and healthcare utilisation. Consequently, IP is a major safety concern and with changing population demographics, it is likely to become even more prevalent in the future. IP can be detected using explicit or implicit prescribing indicators. Theoretically, the routine clinical application of these IP criteria could represent an inexpensive and time efficient method to optimise prescribing practice. However, IP criteria must be sensitive, specific, have good inter-rater reliability and incorporate those medications most commonly associated with ADEs in older people. To be clinically relevant, use of prescribing appropriateness tools must translate into positive patient outcomes, such as reduced rates of ADEs. To accurately measure these outcomes, a reliable method of assessing the relationship between the administration of a drug and an adverse clinical event is required. The Naranjo criteria are the most widely used tool for assessing ADE causality, however, they are often difficult to interpret in the context of older patients. ADE causality criteria that allow for the multiple co-morbidities and prescribed medications in older people are required. Ultimately, the current high prevalence of IP and ADEs is unacceptable. IP screening criteria need to be tested as an intervention to assess their impact on the incidence of ADEs in vulnerable older patients. There is a role for IP screening tools in everyday clinical practice. These should enhance, not replace good clinical judgement, which in turn should be based on sound pharmacogeriatric training.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914 · cited 1×
“The Naranjo criteria are often used to assess ADE causality (see additional file 2), with interrater agreement scores superior to subjective clinical judgement [21].”
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Fick, D. M., Cooper, J. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2716 · Cited by 2,389 · cited 1×
“They were originally designed for older nursing home residents, but were revised in 1997 [11] and 2002 [12] to be universally applicable to older patients.”
Mangoni, A. A., & Jackson, S. H. D. (2004) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.02007.x · Cited by 1,874 · cited 2×
“This risk is compounded by age-related changes in physiology and body composition, which influence drug handling and response [2].”
Gallagher, P., Ryan, C., Byrne, S., Kennedy, J., & OMahony, D. (2008) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp46072 · Cited by 1,506
Self-citationExplicit Criteria for Determining Inappropriate Medication Use in Nursing Home Residents
Beers, M. H. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400090107019 · Cited by 1,201
Appropriate prescribing in elderly people: how well can it be measured and optimised?
Spinewine, A., Schmader, K. E., Barber, N., Hughes, C., Lapane, K. L., Swine, C., & Hanlon, J. T. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61091-5 · Cited by 1,090
Explicit Criteria for Determining Potentially Inappropriate Medication Use by the Elderly: An Update
Beers, M. H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440350031003 · Cited by 1,059 · cited 1×
“They were originally designed for older nursing home residents, but were revised in 1997 [11] and 2002 [12] to be universally applicable to older patients.”
A method for assessing drug therapy appropriateness☆
Hanlon, J. T., Schmader, K. E., Samsa, G. P., Weinberger, M., Uttech, K. M., Lewis, I. K., Cohen, H. J., & Feussner, J. R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90144-c · Cited by 960 · cited 2×
“Consequently, the MAI is predominantly used as a research tool.”
Gallagher, P., & O'Mahony, D. (2008) · Age and Ageing · doi:10.1093/ageing/afn197 · Cited by 697 · cited 4×
“It is possible that Beers' criteria simply do not list those medications most commonly associ-BMC ated with preventable ADEs in older people, as suggested by a recent Irish study which reported that 12% of hospital admissions were related to ADEs resulting from STOPP criteria PIMs, with only 6% resulting from Beers' c…”
InfluentialSelf-citationIncidence and preventability of adverse drug events in nursing homes
Gurwitz, J. H., Field, T. S., Avorn, J., McCormick, D., Jain, S., Eckler, M., Benser, M., Edmondson, A. C., & Bates, D. W. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00451-4 · Cited by 640 · cited 2×
“Evidence suggests that suboptimal or inappropriate prescribing (IP) is highly prevalent in older people and is associated with an increased risk of ADEs, increased morbidity, mortality and healthcare utilisation [5-9].”
Hanlon, J. T., Weinberger, M., Samsa, G. P., Schmader, K. E., Uttech, K. M., Lewis, I. K., Cowper, P. A., Landsman, P. B., Cohen, H. J., & Feussner, J. R. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89519-8 · Cited by 612 · cited 1×
“Other interventions that optimise prescribing appropriateness include comprehensive geriatric assessment [28], clinical pharmacist intervention [ 29 ], prescriber education [30] and computerised decision support tools [31].”
BackgroundMedication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults
Budnitz, D. S., Shehab, N., Kegler, S. R., & Richards, C. L. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-11-200712040-00006 · Cited by 607 · cited 1×
“Some also conclude that Beers' criteria PIMs account for only a small proportion of ADEs in older patients [25,26].”
Onder, G., Pedone, C., Landi, F., Cesari, M., Della Vedova, C., Bernabei, R., & Gambassi, G. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50607.x · Cited by 501 · cited 1×
“Up to 30% of hospital admissions in older people are related to ADEs [ 20 ].”
BackgroundInappropriate Drug Prescribing for the Community-Dwelling Elderly
Willcox, S. M. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520040054040 · Cited by 499
Adverse Drug Events In High Risk Older Outpatients
Hanlon, J. T., Schmader, K. E., Koronkowski, M. J., Weinberger, M., Landsman, P. B., Samsa, G. P., & Lewis, I. K. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb02964.x · Cited by 443 · cited 1×
“Up to 35% of community-dwelling older people experience ADEs each year [19], the incidence being even higher amongst nursing home residents [8].”
Lau, D. T., Kasper, J. D., Potter, D. E. B., Lyles, A., & Bennett, R. G. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.1.68 · Cited by 440 · cited 1×
“Evidence suggests that suboptimal or inappropriate prescribing (IP) is highly prevalent in older people and is associated with an increased risk of ADEs, increased morbidity, mortality and healthcare utilisation [5-9].”
Aged Heterogeneity: Fact or Fiction? The Fate of Diversity in Gerontological Research
Nelson, E. A., & Dannefer, D. (1992) · The Gerontologist · doi:10.1093/geront/32.1.17 · Cited by 434 · cited 1×
“Furthermore, there is marked heterogeneity in health status and functional capacity in older people, often making prescribing decisions complex and challenging [2-4].”
Inappropriate Medication is a Major Cause of Adverse Drug Reactions in Elderly Patients
LINDLEY, C. M., TULLY, M. P., PARAMSOTHY, V., & TALLIS, R. C. (1992) · Age and Ageing · doi:10.1093/ageing/21.4.294 · Cited by 389 · cited 1×
“Evidence suggests that suboptimal or inappropriate prescribing (IP) is highly prevalent in older people and is associated with an increased risk of ADEs, increased morbidity, mortality and healthcare utilisation [5-9].”
HALLAS, J., HARVALD, B., GRAM, L. F., GRODUM, E., BRØSEN, K., HAGHFELT, T., & DAMSBO, N. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00199.x · Cited by 377 · cited 1×
“The Hallas criteria classify ADEs as preventable, probably preventable, probably not preventable or definitely not preventable [22].”
Barry, P. J., Gallagher, P., Ryan, C., & O'mahony, D. (2007) · Age and Ageing · doi:10.1093/ageing/afm118 · Cited by 358
Self-citationTamblyn, R. M., Huang, A. R., Perreault, R. B., Jacques, A., Roy, D., Hanley, J. A., McLeod, P. J., & Laprise, R. (2003) · Europe PMC (PubMed Central) · Cited by 345
Schmader, K. E., Hanlon, J. T., Pieper, C. F., Sloane, R., Ruby, C. M., Twersky, J., Francis, S. D., Branch, L. G., Lindblad, C. I., Artz, M., et al. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.031 · Cited by 334 · cited 1×
“Other interventions that optimise prescribing appropriateness include comprehensive geriatric assessment [28], clinical pharmacist intervention [29], prescriber education [30] and computerised decision support tools [31].”
Is inappropriate medication use a major cause of adverse drug reactions in the elderly?
Laroche, M., Charmes, J., Nouaille, Y., Picard, N., & Merle, L. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02831.x · Cited by 317 · cited 2×
“Some also conclude that Beers' criteria PIMs account for only a small proportion of ADEs in older patients [25,26].”
Klarin, I., Wimo, A., & Fastbom, J. (2005) · Drugs & Aging · doi:10.2165/00002512-200522010-00005 · Cited by 300
Page, R. L., & Mark Ruscin, J. (2006) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2006.12.008 · Cited by 177 · cited 1×
“Some studies have demonstrated no increased risk of ADEs in patients receiving Beers' criteria medications [23-25].”
Pimlott, N., Hux, J. E., Wilson, L., Kahan, M., Li, C., & Rosser, W. (2003) · Europe PMC (PubMed Central) · Cited by 166
Use of Potentially Inappropriate Drugs in Nursing Homes
Dhall, J., Larrat, E. P., & Lapane, K. L. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.1.88.33503 · Cited by 73 · cited 2×
“IP is highly prevalent in older people, with up to 24% of community-dwelling patients [16] and 40% of nursing home residents in the United States [17] regularly receiving at least one potentially inappropriate medicine (PIM) according to Beers' criteria.”
WOODHOUSE, K. W., & O'Mahony, M. S. (1997) · Age and Ageing · doi:10.1093/ageing/26.4.245 · Cited by 60 · cited 1×
“Furthermore, there is marked heterogeneity in health status and functional capacity in older people, often making prescribing decisions complex and challenging [2-4].”
Does the patient-centred approach help identify the needs of older people attending primary care?
Smith, F. J., & Orrell, M. W. (2007) · Age and Ageing · doi:10.1093/ageing/afm131 · Cited by 49
Cited by
Potentially Inappropriate Medications in the Elderly
Holt, S., Schmiedl, S., & Thürmann, P. A. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0543 · Cited by 791
Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions
Corsonello, A., Pedone, C., & Incalzi, R. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416326 · Cited by 391
Preoperative Assessment of the Older Patient: A Narrative Review
Oresanya, L. B., Lyons, W. L., & Finlayson, E. (2014) · JAMA · doi:10.1001/jama.2014.4573 · Cited by 344
Irrational Use of Medicines—A Summary of Key Concepts
Ofori-Asenso, R., & Agyeman, A. (2016) · Pharmacy · doi:10.3390/pharmacy4040035 · Cited by 287
Hanlon, J. T., & Schmader, K. E. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0118-4 · Cited by 242
Metadata
- Authors
- Hamilton, H. J., Gallagher, P. F., & O'Mahony, D.
- Venue
- BMC Geriatrics
- Published
- 2009-01-28
- Volume
- 9
- Issue
- 1
- Pages
- 5-5
- ISSN
- 1471-2318 (ISSN-L)
- OpenAlex
- W2052005998
- Cited by
- 224
- References
- 30
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.